Ann Arbor Stage II Non-Hodgkin Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Doxorubicin (DB00997)

Indication	Status	Phase
DBCOND0113043 (Ann Arbor Stage II Non-Hodgkin Lymphoma)	Active Not Recruiting	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00972478	Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma	Treatment	Acetaminophen (DB00316) Brompheniramine (DB00835) Cortisone (DB14681) Cyclophosphamide (DB00531) Doxorubicin (DB00997) Methylprednisolone (DB00959) Phenylephrine (DB00388) Prednisone (DB00635) Rituximab (DB00073) Sulfate ion (DB14546) Vincristine (DB00541) Vorinostat (DB02546)